Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

The market for these drugs is expected to grow.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.

To improve use of the contraceptive DMPA among adolescents, effectively manage side effects like menstrual changes and weight gain through counseling and guidance.

A substance called 15-deoxy prostaglandin J2 can cause hair follicle cells to die, which might explain how prostaglandin D2 can lead to hair loss.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

A new topical treatment using micelles shows promise for safer and more effective hair regrowth in androgenetic alopecia.

The new gel for hair loss is safe, effective, and reduces side effects.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Somatostatin analogues effectively manage ectopic ACTH syndrome when surgery isn't possible.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

Dutasteride is more effective than finasteride for hair growth with similar side effects.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Dutasteride is more effective than finasteride for hair growth, and sublingual apomorphine quickly improves Parkinson's symptoms.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

The document concludes that H2-antagonists and proton pump inhibitors are highly effective for ulcers, eradicating Helicobacter pylori is important to prevent recurrence, and misoprostol helps with NSAID-related ulcers.